LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry ...

“But with these individuals now gone, companies fear we are entering a period of years to build back up an experienced workforce.” One biotech has already received conflicting feedback from a ...

Thousands of biotech companies are competing against each other for tiny market or revenue opportunities. Holz opined that venture funds should stop making so many companies that end up ...

Biotech companies create drugs from living organisms, requiring a BLA for FDA approval. Pharma companies develop drugs from chemicals, needing an NDA for FDA approval. Many firms blend biotech and ...